Live 1 update · Last at 2:36pm ET Updates appear automatically.

Live: Will Rocket Lab Smash Q3 Earnings Tonight After Jumping 10% Intraday?

By Thomas Richmond · Updated Nov 9, 2:36pm ET · Published Nov 9, 2:38pm ET

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Live Updates

Newest first

Rocket Lab Stock Faces a Massive Test in Q3 Earnings Tonight as Neutron Deadline Approaches

Rocket Lab reports Q3 earnings tonight, and investors will be watching Neutron above all else.

The company’s Q4 2026 launch pad delivery target is approaching fast, which makes any update on Neutron’s development schedule a potential stock-moving catalyst.

Wall Street expects $257.18 million in revenue, compared with management’s guidance of $250 million to $265 million. However, GAAP gross margins are expected to fall to 29%–31%, down from 36.1% last quarter.

The big question tonight: Can management reassure investors that Neutron remains on schedule, or will another potential delay raise concerns about cash burn and future dilution?

This article is updated throughout the trading day. Check back for more.

Full Coverage

The story so far

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) is expected to post third-quarter earnings today, November 9, at 4:05 PM ET. Shares rose 10.02% today to $58.39 but remain 18.81% lower over the past month.

RKLB price target

Rocket Lab’s Record Backlog Meets a Margin Reset

Q2 revenue reached a record $234.07 million, up 62.0% YoY and ahead of the $230.94 million estimate. GAAP EPS of -$0.08 missed expectations of -$0.0767, hurt by $8.58 million in purchase costs. Non-GAAP gross margin expanded to 41.5% from 36.9%.

Backlog hit a record $2.36 billion, up 137% YoY, and CEO Peter Beck highlighted more than $1 billion in new Q3 orders. Iridium Communications (NASDAQ:IRDM) stockholders approved Rocket Lab’s proposed acquisition on September 24, 2026, with closing expected for mid-2027.

Shares still fell 21.32% in the 30 days after the Q2 report and sit 16.3% lower year to date. Dilution stays in focus after $1.53 billion in ATM proceeds during the first half.

Rocket Lab’s Consensus Estimates

Metric Q3 2026 Estimate YoY Change FY 2026 Estimate FY 2027 Estimate
Revenue $257.18M +65.8% $959.22M $1.33B
EPS (Normalized) -$0.0665 Wider vs. -$0.03 -$0.2748 -$0.0912

The revenue estimate implies growth accelerating past Q2’s rate. EPS estimates have drifted lower, with two downward revisions in 30 days and the average sliding from -$0.06 90 days ago. The FY 2027 EPS range of -$0.28 to $0.02 shows wide disagreement on the profitability timeline.

What to Watch Tonight: Neutron Timing, Margins and Cash Burn

Here are some of the top items I’m watching tonight in Rocket Lab’s Q3 earnings:

  1. Neutron schedule. Management said the window for an end-year launch is narrowing. Beck called stage testing the milestone that “gets your adrenaline going.” Investors will be watching whether they confirm pad delivery and stage-test dates.
  2. Margin mix. Satellite platforms run in the “mid-30s” while some products make “north of 70%.” The recently acquired Mynaric business starts at lower margins, so analysts will focus on how quickly it moves toward merchant levels.
  3. Cash burn. Non-GAAP free cash flow was a use of $110.1 million in Q2. Adam Spice linked adjusted EBITDA positivity to the quarter following Neutron’s first successful flight.
  4. Launch and pricing. Rocket Lab logged 13 launches at 100% mission success by the Q2 call. I’ll be following Neutron pricing discipline around its $50 million to $55 million ASP.
  5. Backlog conversion. Management projected 45.5% of backlog converting to revenue within 12 months.

Rocket Lab Earnings History

Quarter EPS Surprise 1-Day Move 7-Day Move 30-Day Move
Q2 2026 -4.3% +1.45% -1.06% -21.32%
Q1 2026 +11.05% +11.26% +18.3% -0.4%
Q4 2025 +8.16% +2.71% +1.46% -7.06%
Q3 2025 +71.29% -2.48% -16.51% +20%
RKLB earnings explorer

Over the past year, shares moved 0.55% in the week following earnings on average.

Contact [email protected] for any questions or corrections.

Thomas Richmond

Thomas Richmond is a financial writer and content strategist with 5+ years of experience covering stocks and financial markets. He has published over 500 articles focused on individual stock analysis, helping investors better understand business fundamentals, stock valuations, and long-term opportunities.

Thomas previously served as a Content Lead at TIKR, a stock research platform, where he helped scale the company’s blog to hundreds of articles per month and contributed to a weekly newsletter reaching more than 100,000 investors.

Outside of work, Thomas enjoys weight lifting and soccer.

All articles →